OptimizeRx Corporation
OPRX
$6.60
$0.172.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6,535.90% | 108.54% | 138.21% | 68.13% | 98.12% |
| Total Depreciation and Amortization | -0.38% | -0.20% | -0.20% | 0.70% | 6.59% |
| Total Amortization of Deferred Charges | 47.27% | -7.30% | 101.58% | 4.74% | -19.12% |
| Total Other Non-Cash Items | -22.76% | -80.62% | -48.73% | -50.63% | -74.02% |
| Change in Net Operating Assets | 59.64% | -73.57% | -95.26% | -29.81% | 72.59% |
| Cash from Operations | 3,479.80% | 78.78% | 483.25% | 82.44% | 103.16% |
| Capital Expenditure | 35.29% | 44.44% | 77.78% | 15.63% | -240.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 310.68% | 100.00% | 15.00% | 52.89% | -100.19% |
| Cash from Investing | 271.67% | 89.13% | 48.24% | 45.10% | 99.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -800.00% | 0.00% | -46.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -196.91% | -200.00% | 98.80% | 37.86% | -121.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.10% | 51.50% | -392.35% | 8.28% | -107.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.06% | 151.41% | 105.50% | 140.98% | -169.89% |